News

News
Partner news

Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies

Read full story
Partner news

CVRx® Secures $113 Million in New Financing

Read full story
Partner news

Torax Medical, Inc. Raises $25 Million in Series E Funding and Welcomes New Chief Commercial Officer

Read full story
Partner news

Merus Enters into 72.8 million Euro Series C Financing

Read full story
Partner news

Catalyst Biosciences Completes Merger with Targacept and Creates a Protease-Based Hemostasis and Anti-Complement Company

Read full story
Partner news

Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience

Read full story
Partner news

Aquinox Pharmaceuticals Commences Phase II Clinical Trial of AQX-1125 in Bladder Pain Syndrome/Interstitial Cystitis

Read full story
Partner news

Celladon Corporation Announces First Patient Dosed in CUPID Phase 2b Trial of MYDICAR® for Advanced Heart Failure

Read full story
Partner news

Allergan and Molecular Partners Enter into Exclusive Alliance

Read full story
Partner news

PhaseBio Pharmaceuticals Initiates a Multicenter, Randomized Placebo and Active Comparator Controlled Phase 2b Trial to Evaluate use of Glymera for the Treatment of Uncontrolled Type 2 Diabetes

Read full story
Partner news

Genocea Initiates a Phase 1/2a Study with Its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2)

Read full story
Partner news

Publication of Clinical Trial Data for New Snoring Therapy

Read full story
Partner news

GI's Successful Raising Lifts IPO Market Dynamics

Read full story
Partner news

Isconova and Genocea Expand Collaboration

Read full story
Partner news

Johnson & Johnson Invests in Israel's LifeBond

Read full story